Source:http://linkedlifedata.com/resource/pubmed/id/10635068
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
12
|
| pubmed:dateCreated |
2000-1-31
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0248-8663
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
20
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1077-81
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:10635068-Antirheumatic Agents,
pubmed-meshheading:10635068-Humans,
pubmed-meshheading:10635068-Penicillamine,
pubmed-meshheading:10635068-Prognosis,
pubmed-meshheading:10635068-Scleroderma, Systemic,
pubmed-meshheading:10635068-Skin Diseases,
pubmed-meshheading:10635068-Survival Analysis
|
| pubmed:year |
1999
|
| pubmed:articleTitle |
[D-penicillamine: an outdated cure for systemic scleroderma?].
|
| pubmed:publicationType |
Journal Article
|